Liverpool firm secures £900k Middle East deal

Liverpool orthopaedic products manufacturer and distributor Algeos secures £900,000 deal to supply products across the Middle East. Tony McDonough reports

Max-Sheridan, left, with Mustafa-Mukbil-and the clinical team from Saudi Arabia


Specialist Liverpool manufacturer and distributor Algeos has secured a £900,000 Middle East supply deal.

Originally founded in Liverpool in 1881 by John Algeo as a leather dealing business, Algeos is now a manufacturer of podiatry, orthotics and footwear products and technologies. It has a global customer base and supplies 85% of the 295 NHS trusts across the UK.

In this latest deal it will supply diabetic footwear, orthotic and prosthetic materials, foot orthotics and other consumables that improve patients’ lives. These will be distributed to local agents, distributors and hospitals across the Middle East.

Algeos has been unveiled as the UK provider of diabetic footwear products to six Sul Cooperaton Council (GCC) member states. They are the United Arab Emirates, Kingdom of Bahrain, Kingdom of Saudi Arabia, Sultanate of Oman, State of Qatar and the State of Kuwait.

Diabetes is a rapidly growing disease that is affecting people worldwide, particularly due to the rise in unhealthy lifestyles and increased risk factor levels. The Middle East has seen a spike in the occurrence of diabetes and the ulceration of the diabetic foot.

Algeos’ products can enable diagnosis, prevention and life-saving solutions to prevent diabetic foot ulcers across a number of hospitals in the six GCC states. It has also provided expert training to a number of Saudi Arabian clinicians.

Max Sherridan, Algeos managing director, said: “It’s been a team effort to ensure we were successful. We have collaborated with our local partners in the regions to ensure that Algeos’ range of products are the preferred choice of clinicians in the Middle East.

READ MORE: Algeos is sole distributor of 3D shoe insert printer

“We look forward to supporting our partners and clinicians to ensure patient outcomes are maximised as part of this tender win.”

Algeos has “big ambitions” to grow in the next three years. It is looking to break into untapped markets, generating profitable growth and retaining its status as an industry leader.

Mustafa Mukbil, business manager at Zimmo Co. added: “My team and I are very grateful to Max Sheridan and the Algeos team. Algeos has been very impressive, as has the country and the people we have met during our time visiting the warehouse and surveying the products. I couldn’t recommend working with Algeos enough.”

You might also like More from author

Leave A Reply

Your email address will not be published.

Username field is empty.